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Summary
Cell migration within a natural context is tightly con-
trolled, often by specific transcription factors. How-
ever, the switch from stationary to migratory behavior
is poorly understood. Border cells perform a spatially
and temporally controlled invasive migration during
Drosophila oogenesis. Slbo, a C/EBP family transcrip-
tional activator, is required for them to become migra-
tory. We purified wild-type and slbo mutant border
cells as well as nonmigratory follicle cells and per-
formed comparative whole-genome expression profil-
ing, followed by functional tests of the contributions of
identified targets to migration. About 300 genes were
significantly upregulated in border cells, many depen-
dent on Slbo. Among these, the microtubule regulator
Stathmin was strongly upregulated and was required
for normal migration. Actin cytoskeleton regulators
were also induced, including, surprisingly, a large
cluster of ‘‘muscle-specific’’ genes. We conclude that
Slbo induces multiple cytoskeletal effectors, and that
each contributes to the behavioral changes in border
cells.
Introduction
In complex, multicellular animals, cell migration is a very
tightly controlled process. Specific cells migrate at spe-
cific times during development and, to a lesser extent, in
adult animals. While cells of the immune system may be
considered professional migratory cells, most other
cells are only migratory in a specific phase; their migra-
tory behavior needs to be activated and later inacti-
vated. Examples are neurons, glial cells, neural crest de-
rivatives, germline cells, as well as certain muscle cells.
If the migratory cells arise in an epithelium, the cells may
undergo an epithelial-to-mesenchymal transition to be-
come migratory. Like other cell fate changes, induction
of migratory behavior can be triggered by specific sig-
nals and transcription factors and is associated with
changes in gene expression (Birchmeier and Brohmann,
2000; Gammill and Bronner-Fraser, 2002; Montell, 2001;
Rørth, 2002). The transcription factors are, however, dif-
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Radcliffe Hospital, Headington, OX39DS, United Kingdom.ferent for different situations. To understand how ex-
actly cells become migratory, it is therefore necessary
to understand which genes are regulated downstream
of the transcription factors that induce the switch.
Once this is understood for specific, well-characterized
transitions, the patterns can be compared to determine
whether there is a common gene expression cassette
that is regulated for cells to become migratory. Alterna-
tively, each cell type may employ a different strategy to
release itself from the constraints of a tissue and move
away. So far, a complete expression profile reflecting
the transcriptional switch has not been obtained from
any controlled cell migration process.
While controlled cell migration behavior is useful for
animal development, it also has pathological correlates.
If tumor cells originating in an epithelium become migra-
tory, this will likely contribute to their ability to metasta-
size and therefore be dangerous. A large number of
studies have analyzed metastasis-associated gene ex-
pression. This has been done by comparison of cell lines
with different migratory or metastatic potential, which, if
done in vitro, may be problematic (Tatenhorst et al.,
2005). Another, more physiological approach is to com-
pare gene expression profiles of groups of metastatic
and nonmetastatic tumors of a particular type (van ’t
Veer et al., 2002; Dyrskjot et al., 2003). The latter ap-
proach appears to be very useful for collecting predic-
tive markers for metastasis, but, given the complexity
of metastasis, it is likely less useful for understanding
how cells become migratory. A more refined analysis
to identify genes specifically involved in cell migration
in this context was done by capturing the cells within
a tumor that are most motile and analyzing their expres-
sion profiles (Wang et al., 2004). As metastasizing tumor
cells may need to reactivate a developmental program
normally used by cells to become migratory, studies of
normal migratory switches are also likely to contribute
to our understanding of metastasis.
To analyze how cells become migratory in response to
a normal transcriptional switch, we have analyzed gene
expression patterns in border cells of the Drosophila
ovary. Border cells are a small group of cells that per-
form a well-defined and controlled migration in vivo
and have become a useful model for studying invasive
cell migration (Montell, 2001; Rørth, 2002). Border cells
delaminate from the follicular epithelium, invade into
the underlying germline tissue, and migrate to the oo-
cyte. One of the key transcription factors inducing
migration of border cells is Slbo (Drosophila C/EBP). Ex-
pression of Slbo requires a spatial signal (unpaired) from
the preexisting anterior polar cells to induce activation
of the JAK/STAT pathway in the prospective outer bor-
der cells. The anterior polar cells will become the central
two cells of the border cell cluster. Together with tempo-
ral signals, this leads to the determination of border
cells, and thus specific expression of Slbo, at the ante-
rior tip of an egg chamber at a specific time. The effect
of Slbo, in turn, appears to be relatively direct, as the
border cells migrate a few hours after Slbo is expressed.
Slbo expression is essential for border cell migration.
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499Slbo is also expressed in centripetal cells at a slightly
later stage, but it is not required for their migration. To
understand how border cells become migratory in re-
sponse to Slbo, we need to know which genes are reg-
ulated by Slbo in border cells. In order to determine
this, we have carried out genome-wide transcription
profiling of border cells purified directly from ovaries.
We compared wild-type border cells with their slbo mu-
tant counterparts and also compared border cells with
neighboring follicle cells of the same developmental
stages. Further functional studies with mutations in
these genes identified a number of genes that affect
the process, but they have also revealed that the pro-
cess is fairly robust.
Results and Discussion
Gene Expression Profiling of Border Cells
and Validation
Border cells arise from the follicular epithelium at stage
8/9 of oogenesis and then delaminate and migrate. In or-
der to identify genes specifically expressed in this small
cluster of invasive cells, we decided to compare the
gene expression profile of border cells to that of all other
follicle cells from the same stages. This was done to en-
sure that the cells compared were from the same envi-
ronment and of the same general maturation stage.
For example, all of these cells are postmitotic. Border
cells were labeled in vivo by expression of GFP with a
specific GAL4 ‘‘driver’’ called c522 that drives expres-
sion only in border cells (Figure 1A). The GAL4 driver
c323 similarly allowed labeling of the other follicle cells
(Figure 1C). To identify genes regulated by Slbo in bor-
der cells, we decided to compare the gene expression
profile of wild-type border cells to that of slbo mutant
border cells, by using the slbo1310 female sterile allele
in trans to a null allele (slboe7b). Phenotypically, this
combination is very strong, and mutant border cells do
not migrate (Figure 1B); thus, the differences in tran-
scriptional output responsible for the migration defect
should be revealed. The mutant border cells were la-
beled as described for the wild-type border cells. To
purify the border cells (or follicle cells), stage-9 egg
chambers were enriched by timed incubation of the fe-
males, and whole ovaries were dissected.A protocol for fluorescence-activated cell sorting
(FACS) had been established for isolating GFP-labeled
follicle cells (Bryant et al., 1999). We modified the proto-
col to minimize handling time, but we found in either
case that border cells were not recovered from the
FACS. Visual inspection of the sample showed that
while follicle cells were dissociated to single cells, bor-
der cells tended to remain as a cluster (Figure 1D), sug-
gesting that adhesion between border cells is particu-
larly strong. By modifying the FACS sorting such that
the pressure on the cells was reduced, we were able
to purify these rare border cell clusters to high purity
without disrupting them (Figures 1E and 1F). Normal
and slbo mutant border cells were purified in this man-
ner, as were the follicle cells for comparison (Figure 1G).
Sorted cells from multiple samples were pooled and
RNA was extracted (Figure 1H) and subjected to linear
mRNA amplification (Figure 1I) and labeling for hybrid-
ization to Drosophila Affymetrix arrays. One technical
replicate, using the same border cell total RNA pool as
starting material, demonstrated the reproducibility of
the method (Figure 1J). Multiple biological replicates (in-
dependent pools of collected material) allowed us to
identify which expression changes could truly be con-
sidered cell type and genotype dependent (Figures 1K
and 1L; see tables in the Supplemental Data available
with this article online). In total, about 5000 genes were
reproducibly detected on the array. The remaining
9000 genes represented on the array may not be detect-
ably expressed in this cell type. In addition, some genes
may have been missed if the probe set was not optimal.
The array results were externally validated as follows:
we selected 20 genes with different levels of expression
and different extents of change in the array analysis, and
we analyzed their expression by quantitative real-time
RT-PCR (QRT-PCR) on RNA not previously amplified.
In all cases tested, the changes observed in the arrays
were confirmed (Figure 1M). This validates the linear am-
plification used to generate probe material for the arrays
as well as the array hybridization and quantification.
To further confirm that differences in RNA abundance
uncovered by the array analysis reflected real dif-
ferences in gene expression in the tissue, we analyzed
expression by in situ methods. We focused on genes up-
regulated at least 2-fold in border cells relative to follicleFigure 1. Purification of Border Cells and Follicle Cells, Array Analysis, and Validation
(A and B) (A) Wild-type and (B) slbo mutant border cells (arrows) labeled with c522-GAL4-driven expression of UAS-actinEGFP (green); late
stage-9 egg chambers. Anterior is oriented toward the left; border cells migrate toward the oocyte (right); phalloidin labels F-actin (red). The scale
bars = 20 mm.
(C) Wild-type stage-9 egg chamber with follicle cells (arrowhead) labeled by c323-GAL4 + UAS-actinEGFP.
(D) Merged fluorescent and bright-field images of a GFP-labeled border cell cluster in the crude suspension of dissociated cells.
(E) FACS plot used to identify GFP-labeled border cells. GFP-positive events are 0.4% of the total population.
(F) Purified GFP-border cell clusters after FACS.
(G) FACS plot used to purify GFP-labeled follicle cells (w20% of the total population).
(H) Electrophoretic analysis on a few picograms of total RNA extracted from border cells or follicle cells. The ribosomal RNAs are visible as a dou-
ble band.
(I) Electrophoretic analysis of amplified antisense RNA generated from 30 ng total RNA from each sample after amplification and biotin labeling.
(J–L) scatter plots of gene expression comparisons from different hybridizations. Represented by dots are the 14,010 probe sets present in the
Drosophila Genome Array. (J) Technical replicate; two experiments were performed on one RNA collection from wild-type border cells. (K and L)
Hybridization profiles of wild-type border cells (WT BCs) versus follicle cells (FCs) and wild-type versus slbo mutant border cells (slbo BCs), re-
spectively.
(M) Validation for selected genes by quantitative real-time RT-PCR, done in triplicate on each of three independent RNA samples (for CG9629 and
Hex-C, only on two samples) for each genotype. Data are reported as fold change between wild-type border cells (set to 1) and follicle cells or
slbo mutant border cells. ‘‘*’’ indicates a transcript not detected.
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ated with Migratory Border Cells
(A–C) Diagrams representing genes with sig-
nificant and at least 2-fold change in RNA level
in wild-type border cells (wt BCs) compared
to follicle cells (FCs) and slbo mutant border
cells (slbo BCs), respectively. (A) Genes up-
regulated in wild-type border cells. (B) Genes
downregulated in wild-type border cells. (C)
Overlap of genes expressed at a high level in
wild-type border cells (blue) and genes ex-
pressed at a higher level in slbomutant border
cells (yellow).
(D–F) Pie charts showing the relative distribu-
tion according to seven functional categories
of genes found upregulated at least 2-fold in
wild-type border cells; the cytoskeleton-as-
sociated genes upregulated in both compari-
sons are listed.
(G) Representation of the functional groups in
the Drosophila genome. For (D)–(G), only
genes with some functional annotation were
included: D:216, E:66, F:118, and G:6537
genes.cells. Of these, 5 genes were already known to be en-
riched in border cells, namely, torso-like, singed, eya,
fas3, and upd. To analyze more genes in an unbiased
manner, we performed RNA in situ analysis and col-
lected available antibodies as well as gene or protein
traps, which allow for visualization of endogenous ex-
pression by GFP. The results of this survey are pre-
sented in Figure S1 and in the panels of the figures con-
tained below and are annotated in Table S1. Previous
experiments had indicated that RNA in situ analysis
could be difficult for border cells and follicle cells owing
to low signal as well as background or obscuring signal
from nurse cells. Of 38 probes tested, only 6 gave signal
above background in follicle cells, but all 6 verified the
predictions from the arrays. All 6 tested antibodies,
and 10 of the 11 gene or protein traps verified the ex-
pected expression difference. Thus, expression differ-
ences were verified in situ for an additional 22 (of 23)
‘‘random’’ genes, giving confidence that the genes iden-
tified in this analysis are truly regulated in vivo.
The polar cells are two pairs of specialized cells within
the follicular epithelium that serve as signaling centers.
Within the border cell cluster, the two central cells are
polar cells. These cells do not appear to have a truly mi-
gratory phenotype and do not require slbo expression,
but they are carried along by the outer border cells.
However, polar cell-enriched genes should score as up-
regulated in border cells by our analysis, as there are
only 2 polar cells per 1000 cells in the remaining follicle
cell population, compared to 2 out of 8–10 border cells.
The in situ analyses showed polar cell-enriched expres-
sion for 6 of the 27 analyzed genes (Table S1), indicating
that such genes were identified but constitute a minority
of the ‘‘border cell-enriched’’ genes.
General Analysis of the Expression Profiles
In the overall comparison, we found 293 genes signifi-
cantly and, on average, at least 2-fold upregulated in
border cells relative to follicle cells (Figure 2A and Table
S1). When comparing wild-type border cells to slbo mu-
tant border cells, 156 genes were at least 2-fold upregu-lated. Interestingly, the overlap between these gene sets
is very high (82 genes, Figure 2A), with 28% of all border
cell-enriched genes positively affected by slbo. The
2-fold cutoff may underestimate the fraction of genes
affected by slbo, as the change in signal level from
wild-type border cells to slbomutant tends to be smaller
than that to follicle cells (see Table S3). Note that the
complimentary overlap between genes reduced in bor-
der cells relative to follicle cells and genes reduced in
wild-type relative to slbo mutant border cells is low
(four genes, Figure 2B, Table S6). Thus, the observed
overlap in upregulated genes is significant and does
not simply reflect that wild-type border cell samples
were used for both comparisons. These results suggest
that a large fraction of the genes upregulated in border
cells is positively regulated by Slbo. As expected, the
polar cell-enriched genes were not regulated by Slbo
(Table S1). Gene expression profiling of mutant cells
does not, of course, show that affected genes are di-
rectly regulated by Slbo. Structure/function analysis of
Slbo (DmC/EBP) has previously shown that its essential
function is that of a simple transcriptional activator
(Rørth, 1994). This was shown for the function of Slbo
during development and has subsequently been con-
firmed for its function in border cell migration (P.R., un-
published data). This would indicate that the key direct
target genes of Slbo are positively regulated, in agree-
ment with the present analysis.
From this general gene expression analysis, we con-
clude that the difference between border cells and adja-
cent follicle cells was larger than the difference between
wild-type border cells and those mutant for a single tran-
scription factor (Slbo). This is based on the number of
genes that change expression significantly as well as
the magnitude of the changes. For example, 91 genes
were at least 10-fold more highly expressed in border
cells than follicle cells, whereas only 7 genes showed
such a difference when comparing wild-type and slbo
mutant border cells. This conclusion was not unex-
pected, as there are multiple differences between bor-
der cells and other follicle cells in addition to the level
Transcriptional Switch Inducing Cell Migration
501Figure 3. Stathmin Expression Is Dependent on Slbo and Is Re-
quired for Proper Border Cell Migration
(A) A Stathmin-specific antibody demonstrates high expression in
migrating border cells (arrow) compared to follicle cells (arrowhead).
(B–D) The Stathmin protein level (red) is severely reduced in slbomu-
tant border outer border cells (arrows), but it is unaffected by slbo in
anterior polar cells (arrowheads). slbo mutant cells are marked by
the absence of GFP (green). DAPI (blue): nuclei. In (C), cells are of
the slbo mutant; in (D) and (E), some border cells are wild-type for
comparison.
(E) The stathmin locus. StathminExC is a viable, fertile deletion of the
first two exons of the stathmin C transcript; stathminL27 deletes the
entire stathmin gene as well as CG31642, Arc-p20, CG9226, and
CG9227.
(F) A stathminL27 mutant border cell clone, marked by the absence of
GFP (arrow), does not migrate (n = 3).
(G) Normal migration in the egg chamber from a stathminexC/
stathminL27 female, with complete loss of the stathmin C transcript.of Slbo. The slbo mutant cells were also not completely
devoid of Slbo protein. A complete absence of Slbo in
border cells can only be obtained in mosaic clones, as
slbo is required for development. This may also contrib-
ute to reducing the magnitude of the differences be-
tween wild-type and slbo mutant cells. Perhaps a more
surprising finding was that a significant number of genes
were high in border cells (which contain high levels of
Slbo) but even higher in slbo mutant border cells
(Figure 2C). One possibility is that they represent com-
pensatory changes in border cells that are not able to
migrate due to the slbo mutation.
All genes showing significant changes were catego-
rized by individual inspection as encoding proteins be-
longing to different functional categories (annotated in
Supplemental Tables). In Figures 2D–2F, all genes regu-
lated at least 2-fold and with some functional annotation
are represented. This was compared to an annotation of
the whole genome (Adams et al., 2000; Figure 2G) to un-
derstand which types of genes were affected. For exam-
ple, one cluster of genes expressed at lower levels in
border cells than in the remaining follicle cells encoded
chorion and vitelline membrane proteins (Figure 2B),
which makes sense given that late-stage follicle cells
produce the vitelline membrane and chorion.
For the genes we were most interested in, the 82
genes upregulated in border cells and by Slbo, many
functional categories were represented (Figure 2E).
Some of these genes should account for the migration
phenotype of slbo mutants, although they may also
serve other functions in border cells. Transcription fac-
tors and other nucleic acid binding proteins were under-
represented, possibly reflecting that we are analyzing
events at the end of a gene regulatory cascade. En-
zymes were somewhat overrepresented but belonged
to many different subgroups with no obvious connec-
tion. These may be Slbo targets, as many of the known
target genes of mammalian C/EBPs encode metabolic
enzymes. Another enriched group of genes was those
encoding cytoskeleton-associated proteins. These are
structural components, motor proteins, or proteins
known to directly regulate dynamics of actin filaments
or microtubules. Migrating cells make use of their cyto-
skeleton to change shape and move through a tissue.
One obvious idea would be that Slbo controls border
cell migration by regulating these genes. To investigate
this, we carried out a more detailed functional analysis
of genes from this category. They fall into two distinct
groups. The first group contains genes, such as stath-
min and singed, known from studies in flies or other
(H and I) Border cell-specific RNAi of stathmin decreases Stathmin
protein levels in a sensitized background, stathminexC/stathminL27;
UAS-stathminRNAi/slbo-GAL4 in (I); compare to wild-type (H). In
(B)–(D) and (H)–(I), right panels shows anti-stathmin alone, and the
left panels show a merged image.
(J and K) Quantification of migration at (J) stage 9 and (K) stage 10 in
border cells with reduced Stathmin levels (stathminexC/stathminL27;
UAS-stathminRNAi/slbo-GAL4) compared to control (stathminexC/
stathminL27; TM3/slbo-GAL4) and ‘‘rescue’’ (UAS-stathmin/+; stath-
minexC/stathminL27; UAS-stathminRNAi/slbo-GAL4).
(L) Overexpression of stathmin in slbo mutant border cells does
not rescue migration. Quantification of slbo1310,slbo-GAL4/slbo1310
and slbo1310,slbo-GAL4/slbo1310;UAS-Stathmin egg chambers at
stage 10.
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(A–C) Egg chambers stained with antibody to Singed. (A) High Singed expression in wild-type stage-9 border cells (arrow) compared to follicle
cells (arrowhead). (B and C) Merged and (B0 and C0) single channel images of a mosaic border cell cluster ([C] at high magnification); slbo8ex2
mutant cells are marked by the absence of GFP and by a yellow arrow; wild-type cells are marked by white arrow. The scale bars are 20 mm.
(D) Stage-9 egg chamber stained with anti-Gelsolin. High Gelsolin expression is detected in polar cells within the border cell cluster (arrow) com-
pared to follicle cells (arrowhead).
(E and F) Late stage-9 egg chambers stained with anti-Quail. (E) Wild-type. (F) Egg chamber with a quail germline mutant clone (GFP negative);
Quail is detected in border cells (arrow).
(G) Quantification of border cell migration in egg chambers at stage 10, when migration is complete in wild-type.organisms to function in many cell types. If we include all
genes upregulated significantly in border cells, quail,
gelsolin, and spire are added. The second group con-
sists of ‘‘muscle-specific’’ genes.
Stathmin, a Regulator of Microtubule Dynamics
Only one of the identified cytoskeletal regulators is
known to affect microtubules, namely, Stathmin. Mam-
malian Stathmin/Op18 protein is well characterized (Bel-
mont and Mitchison, 1996). It binds to microtubules and
promotes depolymerization by sequestration of tubulin
dimers or direct action at microtubule ends (Ravelli
et al., 2004). Interestingly, the activity of Stathmin can
be regulated by phosphorylation in response to signal-
ing or cell cycle phases. Drosophila Stathmin appears
to have similar biochemical features (Ozon et al.,
2002). The availability of an antibody directed against
DrosophilaStathmin allowed us to analyze protein levels
in situ. As expected, the level of Stathmin was higher in
border cells than follicle cells (Figure 3A). When analyz-
ing slbo mutant border cells, we observed a clear differ-
ence between the inner polar cells and the outer border
cells (Figures 3B–3D). The outer border cells are the mi-
gratory cells and require Slbo expression. In these cells,
Stathmin expression was undetectable in the absence
of Slbo, indicating a very strong dependence on Slbo.
In contrast, Stathmin was still expressed in mutant polar
cells, explaining why we only saw a moderate reduction
of stathmin mRNA levels in whole border cell clusters
(Figure 1M).
To analyze the function of Stathmin in border cells, we
generated stathmin mutants. This was done by impre-
cise excision of a P element located immediately up-
stream of the stathmin C transcript (Figure 3E). A mutant
deleting only the stathmin C isoform (stathminexC), leav-ing stathmin A andB intact, was homozygous viable and
had no effect on border cell migration. A mutant deleting
the complete stathmin locus (stathminL27) and four adja-
cent genes (including Arc-p20, a component of the
Arp2/3 complex) was homozygous lethal, and clones
of stathminL27 mutant border cells were unable to mi-
grate (Figure 3F). Both the lethality and the migration
block were rescued by reintroducing ubiquitously ex-
pressed stathmin and Arc-p20 at the same time. Re-
introducing Arc-p20 alone did not rescue border cell
migration, indicating that stathmin is essential for this
process. To interfere with stathmin upregulation at the
time of migration, we expressed a functional stathmin
‘‘hairpin’’-RNAi construct in the sensitized stathminexC/
stathminL27 background (Figure 3G). By using the slbo-
GAL4 driver, we could specifically target stathmin
RNAi expression to outer border cells right before and
during migration. This strongly decreased the amount
of Stathmin protein in border cells (compare Figure 3I
to Figure 3H) and caused significant delays in migration
(Figures 3J and 3K). The delays in migration could be
reversed by driving higher levels of stathmin expression
from a UAS construct (‘‘rescue’’ in Figure 3J). These re-
sults identify Stathmin as an important regulator down-
stream of Slbo. To test whether lack of Stathmin was
solely responsible for the slbo phenotype, we overex-
pressed Stathmin in the slbo mutant background
(Figure 3L). Migration was not restored, indicating that
additional genes downstream of Slbo must also be
important.
Singed and Related Regulators
of the Actin Cytoskeleton
Singed is an actin-bundling protein related to Fascin,
highly expressed in border cells (Figures 1M and 4A;
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503Figure 5. Muscle-Specific Genes and Border
Cell Migration
(A and B) (A) Tropomyosin2-GFP (protein
trap) in migrating border cells (arrow) com-
pared to follicle cells (arrowhead) and (B) in
the muscle sheath that surrounds egg cham-
bers, counterstained for F-actin (phalloidin,
red). The scale bars are 20 mm.
(C) Stage-10 egg chamber with an mhc1 mu-
tant border cell clone (marked by the absence
of GFP) that shows normal migration.
(D) Stage-10 egg chamber with an mhc3 mu-
tant border cell clone (marked by the absence
of GFP) that is delayed (<50%).
(E) Late stage-9 egg chamber with a rolsT627
mutant border cell clone that shows defective
migration (50%).
(F) Quantification of border cell migration in
egg chambers at stage 10 for mhc1, mhc3,
mlc2E38, up101 and rolsT627 mutant border
cell clones, or in tm23 homozygous mutant fe-
males. Controls for mhc1, mhc3, and rolsT627
mutant clones were: mhc1/+ (n = 46), mhc3/+
(n = 21), and rolsT627/+ (n = 20).Cant et al., 1994). Fascin is important for the formation of
cell protrusions and has been implicated in the control of
cell migration, also in vivo (reviewed in Adams, 2004).
We confirmed by clonal analysis that Singed protein
levels were regulated by Slbo (Figures 4B and 4C). De-
spite the strong and regulated expression, migration
was normal in border cells mutant for singed (Figure 4G).
The strongest allele of singed available was used, but it
retained a low level of protein expression (data not
shown). In addition, functional overlap may exist be-
tween actin regulators. Quail is an actin binding protein
of the villin family (Mahajan-Miklos and Cooley, 1994),
and its function in the germline of the ovary genetically
overlaps with that of Singed (Cant et al., 1998). quail
mRNA was also upregulated in border cells relative to
follicle cells (Figure 1M), and Quail protein was detected
in border cells (Figures 4E and 4F). Quail is structurally
similar to Gelsolin, which was also upregulated in border
cells (Figure 1M), as well as the Gelsolin-related FliI,
which was not detectably expressed. However, Gelsolin
was enriched in polar cells rather than the migratory
outer border cells (Figure 4D). As for singed, we ob-
served no migration defects in quail mutant border cells
(Figure 4G), nor in cells mutant for quail and only one
functional copy of singed or vice versa (Figure 4G). We
were not able to recover clones of border cells simulta-
neously mutant for both singed and quail, which is likely
to reflect a functional overlap between the two genes at
an earlier stage. The simultaneous upregulation of re-
dundant actin regulators may reflect a genetically robust
approach to changing the actin cytoskeleton in border
cells.
Activation of a Muscle Gene Expression Program
A rather surprising finding of this global expression anal-
ysis was that the remaining genes encoding cytoskele-
ton-associated proteins and upregulated in border cells
in a slbo-dependent manner were all ‘‘muscle specific’’(Figures 2E and 1M). This included a complete palate
of structural genes: muscle actin (57B), muscle myosin
heavy chain and light chains, tropomyosin 2 (tm2), tro-
ponins, and the calponin-related mp20. The muscle-
specific expression has been shown for this group of
genes inDrosophila embryos as well as mature muscles.
For tropomyosin 2, a GFP gene trap allele was available
and confirmed expression in border cells (Figure 5A) as
well as in the muscle sheath (Figure 5B). The expression
profiling indicated that border cells also expressed the
corresponding non-muscle forms such as actin42A, zip-
per (myosin heavy chain), and sqh (myosin light chain),
but at the same level as in follicle cells. The nonmuscle
proteins are generally required for many cellular pro-
cesses, including, where tested, migration of border
cells (Edwards and Kiehart, 1996). This raised the ques-
tion of why this large cluster of muscle-specific struc-
tural genes would be turned on in border cells as well.
To address this, we analyzed migration of border cells
mutant for individual muscle genes for which mutants
were available (mhc, mlc2, upheld=troponinT and tm2).
As mhc and mlc2 are essential genes, this was done
by clonal analysis. No defects were seen in border cells
mutant for mlc2, upheld, or tm2, but clear migration de-
fects were observed in border cells mutant for mhc
(mhc1 or mhc3, Figures 5D and 5F). Thus, while not all
of the muscle structural genes are required for border
cell migration, at least muscle Mhc expression contrib-
utes to effective migration.
Given that both muscle and nonmuscle forms of the
same cytoskeletal proteins have a role in border cell mi-
gration, their functions are likely to be different. In agree-
ment with this, we did not observe genetic interactions
between mutants affecting muscle and nonmuscle
forms of myosin heavy or light chains (data not shown).
There is precedence for such nonoverlapping functions.
For example, zipper has a unique role in developing
muscle cells, which contain plenty of muscle myosin
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504heavy chain (Bloor and Kiehart, 2001). In mammalian
cells, different myosin heavy chain isoforms can have
distinct subcellular localization (Bresnick, 1999). Also,
the actin proteins, despite having few amino acid dif-
ferences, are functionally distinct in vivo (Fyrberg
et al., 1998; Brault et al., 1999).
The muscle gene expression program activated in mi-
gratory border cells extended beyond structural genes
to regulatory genes. One such gene was bent, encoding
a very large titin-like molecule with a myosin light chain
kinase domain. Being essential but on the fourth chro-
mosome, bent was not amenable to standard clonal
analysis. Genes required for myoblast fusion were also
identified, namely, rols/antisocial (Rau et al., 2001;
Chen and Olson, 2001) and rost. We had previously
shown that mbc, which encodes a DOCK180 family
Rac GEF and is required for myoblast fusion, has
a role in border cell migration downstream of the PVR
guidance receptor (Duchek et al., 2001). Mbc protein in-
teracts physically with the presumed adaptor protein
Rols (Chen and Olson, 2001). Clonal analysis with
a strong (likely complete loss-of-function) allele of rols
showed defects in border cell migration (Figures 5E
and 5F), suggesting that Mbc and Rols might act to-
gether during migration as well. The defect was milder
than for mbc, implying that Mbc activity might not be
completely dependent on Rols. For the small transmem-
brane protein Rost, no useful mutants were available.
We also noted that a very closely related and adjacent
gene, CG13101, was similarly regulated in border cells
and might overlap rost function. Thus, at least mbc
and rols function in border cells as well as in muscle
(myoblast fusion). Activation of a broad ‘‘muscle-
specific’’ gene expression program in border cells may
reflect a requirement for a specific subset of the genes
within this program.
Analysis of Additional Transcription Factors
Previous unbiased genetic approaches to identify genes
important for border cell migration have largely identi-
fied transcription factors or inducing signals. Changes
in cell fate can alter cell behavior dramatically without af-
fecting cell survival, thus still allowing analysis of the
mutant cells. The transcription factors themselves often
show differential expression. In addition to Slbo, the
posttranslationally regulated transcription factor STAT,
which is important for border cell migration, was also
upregulated in border cells (1.6-fold). We tested the
transcription factors that were upregulated in border
cells and had mutants available for effects on border
cell migration. aop/yan transcripts were increased 1.9-
fold in border cells. In a PiggyBac transposon-based
clonal screen for border cell migration defects, we iden-
tified an insertion in aop. Complementation analysis
confirmed the gene assignment, and quantification of
the phenotype showed a clear effect of aop on border
cell migration (Figures 6A and 6B). This requirement
for aop has recently been characterized by another
group (Schober et al., 2005). We also analyzed a com-
plete loss-of-function allele, aop1. As expected, border
cell migration was strongly affected (Figure 6C), but, in
addition, clones were rare and morphological abnormal-
ities were seen in other follicle cells (Figure 6D) as well as
in germline cells. Thus, aop may affect the behavior ofmultiple cell types in the ovary. Another transcription
factor, vrille, was also upregulated (over 2-fold). vrille
has been implicated in signaling, circadian rhythm,
and cellular morphogenesis (Szuplewski et al., 2003),
but border cells mutant for vrille were largely unaffected
and experienced only subtle delays (Figures 6E and 6F).
The most border cell-enriched RNA encoding a tran-
scription factor, apart from Slbo, was Six4 (4.5-fold).
Six4 expression in border cells was confirmed by in
situ analysis (Figure 7A). Drosophila Six4 is the homeo-
domain transcription factor most related to mammalian
Six4 and Six5 (Kirby et al., 2001). Six family proteins act
in complex with proteins of the Eya (Eyes absent) family
(Kawakami et al., 2000). eya transcripts were also 2.7-
fold enriched in border cells relative to follicle cells of
the same stage, and Eya was expressed in a pattern sim-
ilar to that of six4 (Figure 7B). Both six4 and eya were ex-
pressed in earlier-stage follicle cells as well (Figures 7A
and 7B), and eya has been shown to function at these
stages to repress polar cell fate (Bai and Montell,
2002). Follicle cells mutant for six4 expressed a polar
cell marker (Fas3 in Figures 7C0 and 7D) and were func-
tional polar cells, as determined by the ability to induce
surrounding anterior follicle cells to become Slbo-posi-
tive, migratory border cells (Figures 7C and 7D). This
suggested that Six4 cooperates with Eya in repressing
polar cell fate. It had been indicated that Six proteins af-
fect nuclear localization of their Eya partner (Ohto et al.,
1999). The six4mutant allowed us to test this in an in vivo
context. Although six4 mutant cells were transformed to
functional polar cells, Eya protein was not absent as in
the endogenous polar cells, showing that Eya accumu-
lation was independently regulated (arrows in Figure 7F).
Figure 6. Function of Aop and Vrille Transcription Factors in Border
Cells
(A–F) Quantification of migration at stage 10 for (A) aop (yan)PB104
and (E) vrille2 mutant border cell clones. Controls are aopPB/+ and
vrille2/+. (B) Stage-10 egg chamber with an aopPB104 mutant border
cell clone (arrow): delayed migration. (C) Late stage-9 egg chamber
with an aop1 mutant border cell clone. Mutant cells are marked by
the absence of GFP; one cell is GFP positive. (D and D0) An aop1 mu-
tant follicle cell clone in a stage-10 egg chamber. Phalloidin (red) and
DAPI (blue). The scale bar is 20 mm. (F) A vrille2 mutant border cell
clone marked by the absence of GFP (arrow).
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(A) six4 expression detected by RNA in situ hybridization.
(B) Eya expression detected by antibody staining. Early stages are to the left.
(C) Six4289 mutant follicle cell clone (marked by the absence of GFP, arrows) in the anterior of a stage-9 egg chamber stained with anti-Slbo (bor-
der cells, red in [C]) and anti-Fas3 (polar cells, blue in [C0]). Wild-type cells directly in contact with the mutant clone express Slbo (arrowheads).
(D) Stage-10 egg chamber with two border cell clusters (arrowhead: wild-type cluster, arrow: ectopically induced cluster).
(E and F) six4289 mutant follicle cell clones stained with anti-Eya (red). (E) Anterior tip and (F) posterior tip of egg chambers.
(G) Delayed migration in a stage 9 slbo1310, slboGAL4/UAS-HA-six4 egg chamber. HA-Six4 is nuclear.
(H) Quantification of migration in stage-10 egg chambers of the genotype slbo1310, slboGAL4/UAS-HA-six4 and control slbo1310, slboGAL4/+.However, Eya protein was partially relocalized to the cy-
toplasm of six4 mutant cells (Figures 7E and 7F), sup-
porting the hypothesis that Six4 and Eya interact in
vivo. As six4 and eya are both upregulated in outer bor-
der cells when they migrate, they are likely to act to-
gether in this process as well. However, their earlier
roles precludes straightforward loss-of-function analy-
ses in border cells, as ‘‘border cell clusters’’ consisting
only of six4 or eya mutant cells are not functional simply
because polar cells do not migrate on their own. Overex-
pression of HA-tagged six4 in border cells interfered
with migration (Figures 7G and 7H), as found for tran-
scription factors required in border cells slbo (Rørth
et al., 2000) and yan (Schober et al., 2005).
The expression of Six4 in border cells may contribute
to activation of the muscle gene program described
above. The conserved muscle transcription factor
Mef2, an activator of muscle actin and myosin expres-
sion, was not detected in border cells by expression pro-
filing or by antibody staining, nor were Twist and Nauti-
lus/MyoD. Six4 is required for development of muscle
and other mesodermal tissues in Drosophila (Kirby
et al., 2001). Mutants of Caenorhabditis elegans Unc-39
(Yanowitz et al., 2004), belonging to the Six4/5 family,
also affect muscle/mesodermal differentiation as well
as directed cell migration. Mammalian Six5, also calledmyotonic dystrophy-associated homeodomain protein
(DMAHP), has been analyzed due to its contribution to
DM1 (Groenen and Wieringa, 1998), and Six4/5 affect
normal muscle development. Another transcription fac-
tor complex that might contribute to the activation of
the muscle program is that of MAL-D (or MRTF) and
SRF (serum response factor). The MRTF/SRF complex
plays an important role in muscle development in mam-
mals and directly regulates muscle (structural) genes
(Wang and Olson, 2004). We have previously shown
that MAL-D/SRF plays a crucial role in border cell migra-
tion and provided evidence that this complex acts to
strengthen the cytoskeleton of invasive border cells in
response to perceived tension (Somogyi and Rørth,
2004). This mode of regulation makes MAL-D/SRF activ-
ity in border cells indirectly dependent on Slbo (Somogyi
and Rørth, 2004), which could be responsible for the ap-
parent regulation of the muscle gene cluster by Slbo. We
do not, however, want to exclude the possibility that Slbo
might affect muscle genes directly, as the mammalian
C/EBP transcription factors are known to regulate differ-
ent differentiation-specific genes in different contexts.
Conclusions and Perspective
In this study, we have analyzed overall gene expression
changes resulting from a transcriptional switch that
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goal of the analysis was to identify transcriptional
changes that directly affect cell behavior and make the
cells move. Our results indicate that regulation of both
the actin cytoskeleton and the microtubule cytoskeleton,
likely coordinated regulation, is important for this transi-
tion. Identifying Stathmin as an important regulator
downstream of Slbo in border cells indicates that micro-
tubule dynamics are critical for border cell migration. Key
questions are now how microtubule dynamics affect the
process, and whether Stathmin activity is regulated. Two
recent findings suggest that Stathmin may be a more
general regulator of cell migration: Stathmin-microtubule
interactions are spatially regulated in migrating cells
in culture (Niethammer et al., 2004), and Stathmin upre-
gulation may promote migration and metastasis of sar-
coma cells (Baldassarre et al., 2005). The actin cytoskel-
eton is clearly crucial for cell migration and is controlled
by many regulators. The upregulated modulators identi-
fied in this study were different from those identified in
a whole-genome study of tumor cells selected, in vivo,
to be highly motile (Wang et al., 2004). There are obvi-
ously many differences between these studies; for
one, a normal transition to migratory behavior may differ
from unrestrained, high motility. The activation of a
‘‘muscle-specific’’ program in migratory border cells
was unexpected and provides an intriguing connection
between these cells that move and the specialized cells
that move an animal (muscle). Overall, the analysis of ac-
tin regulators indicates that this is a robust system, with
many effectors coregulated, even by one transcription
factor. Genetically, this is reflected by minor defects in
individual ‘‘effector’’ mutants despite absolute depen-
dence on the transcriptional switch. Further analysis in
other systems, and subsequent comparisons, will tell us
to what extent the gene expression program employed
by border cells to become migratory is a general one.
Experimental Procedures
Drosophila Strains and Genetic Analysis
Stathmin mutants were generated by imprecise excision of the
GS2209 P element. A total of 640 w2 excision alleles were analyzed
by PCR, followed by mapping. For lethal alleles, homozygous mu-
tant embryos were recovered from ex/Cyo,twist-GFP stocks. To
generate a stathmin RNAi construct, a 500 bp fragment of the stath-
min coding region common to all three isoforms was amplified by
PCR and cloned in forward and reverse orientation into pGem-WIZ
(kind gift of Sujin Bao). For UASt-Stathmin and pCaSpeR-tub-Stath-
min, a Not1-Xho1fragment was subcloned from LD04103 (full-length
stathmin A). To generate pCaSpeR-tub-Arc-p20, the ORF was ob-
tained by PCR from genomic DNA and cloned with SV40UTR. The
complete six4 ORF was cloned by PCR from the cDNA clone
GM13131 and three HA tags added at the 50 end (UASt-HA-six4).
The aop/yan allele aopPB104 is a PiggyBac insertion in the first intron
of aop-B. The remaining stocks and mutants are described in
Flybase: slboe7b, slbory8ex2, slbo1310, sn36a, qua1, mhc1, mhc3,
mlc2E38, tm23, up101, rolsT627, aop1, vrille2, six4289, the tm2-GFP pro-
tein-trap line, GAL4 drivers GawB-c522 GAL4; GawB-c323a and
slboGAL4. Flies, except c323a/UAS-actinEGFP (22ºC), were raised
on standard medium at 25ºC. Crosses for RNAi (and controls)
were incubated at 29ºC. For clonal analysis, mutants were recom-
bined onto the appropriate FRT chromosomes and checked with de-
ficiencies or other alleles. Clones were induced by heat shocking lar-
vae of the genotype hsFLP/+; FRT, mut/FRT, ubiGFP. For slbory8ex2,
stathminL27, aop1, and six4289 clones, heat shock to adults was also
used, 3–4 days before analysis.Purification by Fluorescence-Activated Cell Sorting
Ovaries enriched in stage 9 (females incubated at 25ºC for 18 hr on
rich food) were dissected (100 pairs/30 min) in ice-cold SFM medium
(GIBCO-BRL-Invitrogen). Ovaries were dissociated by incubation at
room temperature for 30 min in 0.9 ml Trypsin 0.5%/EDTA (Sigma) +
0.1 ml 67 mg/ml Collagenase in PBS (Sigma). Supernatant was fil-
tered through a 62 mm nylon mesh (Small Parts Incorporated) into
tubes containing SFM medium supplemented with 10% fetal calf se-
rum (FCS) to 1 ml final volume, centrifuged at 10003 g for 7 min, and
the pellet was resuspended in 1 ml SFM with FCS and kept on ice un-
til sorting.
Fluorescent-activated cell sorting was performed on a Dako Cyto-
mation MoFlo high-speed flow cytometer, modified in order to re-
cover border cell clusters. A 150 mm nozzle was used at 8 psi sheath
pressure. Minimal sample differential pressure was used to create
a 1000 events per second acquisition trigger rate or less. The light
source used was a Lyt 200-S (iCyt, Urbana IL) 488 nm diode attenu-
ated to 150 mw and shaped to ellipse. GFP expression was captured
in FL1 by using a Chroma HQ520/40 reflected from a 500DCSP, re-
flected from a Chroma Q550LP, and passed through a 605DSP. A
scatter plot was used to exclude apex noise and fragments, and a bi-
variate fluorescence plot using the GFP FL1 on the x axis and the ad-
jacent parameter FL2 on the y axis for dumping background was
also used. Sorting gates to satisfy included the scatter gate and pos-
itive GFP. Multiple sortings were performed and pooled in order to
recover sufficient border cells for microarray experiments.
RNA Extraction, Amplification, and Microarray Hybridization
For RNA extraction, border cell clusters and single follicle cells were
sorted directly in lysis buffer (PicoPure RNA isolation kit, Arcturus,
Mountain View, CA) and frozen at280ºC until subsequent extraction
steps. Total RNA was usually extracted fromw8,000 events of bor-
der cell cluster collection and from 20,000 events of follicle cell-
sorted collection. RNA quality was assessed by using RNA Pico Lab-
Chip together with an Agilent Bioanalyzer (Agilent Technologies,
Palo Alto, CA) and quantified by using the RiboGreen RNA quantita-
tion kit (Molecular Probes).
From each sample, 30 ng total RNA was linearly amplified by in vitro
transcription by using the RiboAmp OA RNA Amplification kit (Arctu-
rus Genomics), followed by the BioArray High Yield transcription kit
(ENZO Biochemical, New York, NY) to generate biotinylated cRNA.
To verify that amplification was consistent between samples for dif-
ferent RNA lengths and sequences, spike-in controls (Bacillus subtilis
gene transcripts detectable by probe sets on the arrays) were in-
cluded prior to initiation of first-strand synthesis. Equivalent amounts
(10–20mg) of fragmented biotin-labeledcRNA from each sample were
hybridized to GeneChip Drosophila Genome Arrays (Affymetrix,
Santa Clara, CA). Hybridization and scanning were performed by
the GeneChip facility of the Siteman Cancer Center (St. Louis, MO).
Microarray Data Analysis
Raw data have been deposited with ArrayExpress at EBI (E-MEXP-
493). Images from scanned chips were processed by using the de-
fault settings of GeneChip Operating Software v.1.0 (GCOS) and
individually scaled to an average target signal of 1500. Pairwise (bor-
der cells versus follicle cells, wild-type versus slbo) comparisons of
transcript levels were performed by using GCOS v.1.0, with each ex-
periment treated independently. The final lists include only genes
significantly changed in the same direction in all independent exper-
iments (p << 0.05), see tables in the Supplemental Data.
Quantitative Real-Time RT-PCR
Quantitative real-time RT-PCR (QRT-PCR) analysis was performed
with SYBR Green PCR Core Reagents (Applied Biosystems, Foster
City, CA) and 7700 Sequence Detection Systems (Applied Biosys-
tems). For cDNA synthesis, 10–20 ng total RNA was reverse tran-
scribed in 20 ml containing 13 buffer from Superscript II RNase
H- kit (Invitrogen), 100 ng oligo-dT, 10 mM DTT, 0.5 mM dNTPs, 40
U RNasin (Promega), 200 U SS Reverse Transcriptase. A total of
100 pg total RNA was used per QRT-PCR in 25 ml containing 13
SYBR Green PCR Master mix, 0.25 U UDP-N-Glycosidase (Invitro-
gen), 300 nM each of the gene-specific primer pair. rp49 was used
as a reference gene. See Supplemental Data for primer sequences
and amplicon sizes.
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In situ hybridizations to wild-type ovaries were performed by using
digoxygenin-labeled antisense RNA probes synthesized with DGC
cDNA clones as templates. For six4, a standard protocol was
used, but for the rest of the genes, an optimized protocol was
used: ovaries were fixed overnight in 4% PFA/PBS Tween 20
(0.1% PBSTw) at 4ºC, washed with PBSTw, and kept in methanol
for >90 min at 220ºC. After rehydration, ovaries were dissociated
and treated with 10 mg/ml proteinase K for 8 min, washed twice
with PBSTw, and refixed for 20 min with 4% PFA/PBSTw, followed
by five quick washes with PBSTw. Egg chambers were prehybrid-
ized for 60 min at 65ºC in 50% formamide, 53 SSC, 1% Boehringer
Block (BB), 1 mg/ml Torula RNA, 0.1 mg/ml heparin, 0.1% Tween
20, 0.1% CHAPS, 5 mM EDTA and hybridized overnight at 65ºC
with 40–100 ng/ml with DIG-labeled RNA antisense probe. Washes
were performed at 65ºC: 23 30 min in 50% fomamide, 53 SSC,
0.1% CHAPS; 15 min in 23 SSC, 0.1% CHAPS; and 23 30 min in
0.23 SSC, 0.1% CHAPS. Samples were rinsed with MABTw (100
mM maleic acid, 150 mM NaCl, 0.1% Tween 20) and blocked in 5%
BB, MABTw for 1 hr. Anti-DIG antibody (Roche) was used at 1:4000
in 5% BB for 2 hr. Samples were washed 63 20 min in MABTw, in-
cubated 33 5 min in 100 mM Tris (pH 9.5), 50 mM MgCl2, 100 mM
NaCl, 0.1% Tween 20, and stained with BM Purple (Roche).
Antibodies
Standard procedures for staining and detection were used with the
following primary antibodies: rat anti-Slbo (1:500); rabbit anti-Stath-
min (1:500, Ozon et al., 2002), rabbit anti-Gelsolin (1:1000, Stella
et al., 1994), rabbit anti-Wb (1:100), mouse anti-Singed (1:100), rabbit
anti-Glutactin (1:500), mouse anti-HA.11 (1:1000, from BAbCO).
From the Developmental Studies Hybridoma Bank: anti-Eya
(EYA10H6, 1:1000), anti-Quail (6B9, 1:25), anti-Fas3 (7G10, 1:50),
anti-Nrt (1:5). Fluorescent secondary antibodies were purchased
from (Jackson ImmunoResearch); rhodamine-phalloidin and DAPI
were purchased from (Molecular Probes).
Supplemental Data
Supplemental Data including confirmation of gene expression pat-
terns by in situ analysis (Figure S1), lists of genes upregulated or
downregulated in border cells versus follicle cells or slbo mutant
border cells (Tables S1–S6), and a list of primers for QRT-PCR are
available at http://www.developmentalcell.com/cgi/content/full/10/
4/497/DC1/.
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